252 related articles for article (PubMed ID: 2543930)
1. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
Clayton LK; Sieh M; Pious DA; Reinherz EL
Nature; 1989 Jun; 339(6225):548-51. PubMed ID: 2543930
[TBL] [Abstract][Full Text] [Related]
2. Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help.
Chirmule N; Wang XP; Hu R; Oyaizu N; Roifman C; Pahwa R; Kalyanaraman VS; Pahwa S
Cell Immunol; 1994 Apr; 155(1):169-82. PubMed ID: 8168144
[TBL] [Abstract][Full Text] [Related]
3. The MHC-binding and gp120-binding functions of CD4 are separable.
Lamarre D; Ashkenazi A; Fleury S; Smith DH; Sekaly RP; Capon DJ
Science; 1989 Aug; 245(4919):743-6. PubMed ID: 2549633
[TBL] [Abstract][Full Text] [Related]
4. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
Hussey RE; Richardson NE; Kowalski M; Brown NR; Chang HC; Siliciano RF; Dorfman T; Walker B; Sodroski J; Reinherz EL
Nature; 1988 Jan; 331(6151):78-81. PubMed ID: 2829023
[TBL] [Abstract][Full Text] [Related]
5. The interaction of CD4 with HIV-1 gp120.
Silberman SL; Goldman SJ; Mitchell DB; Tong AT; Rosenstein Y; Diamond DC; Finberg RW; Schreiber SL; Burakoff SJ
Semin Immunol; 1991 May; 3(3):187-92. PubMed ID: 1888898
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
Mann DL; Read-Connole E; Arthur LO; Robey WG; Wernet P; Schneider EM; Blattner WA; Popovic M
J Immunol; 1988 Aug; 141(4):1131-6. PubMed ID: 2840463
[TBL] [Abstract][Full Text] [Related]
7. Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding.
Clayton LK; Hussey RE; Steinbrich R; Ramachandran H; Husain Y; Reinherz EL
Nature; 1988 Sep; 335(6188):363-6. PubMed ID: 2843773
[TBL] [Abstract][Full Text] [Related]
8. A fungal metabolite which inhibits the interaction of CD4 with major histocompatibility complex-encoded class II molecules.
Gammon G; Chandler G; Depledge P; Elcock C; Wrigley S; Moore J; Cammarota G; Sinigaglia F; Moore M
Eur J Immunol; 1994 Apr; 24(4):991-8. PubMed ID: 8149967
[TBL] [Abstract][Full Text] [Related]
9. HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4.
Houlgatte R; Scarmato P; el Marhomy S; Martin M; Ostankovitch M; Lafosse S; Vervisch A; Auffray C; Platier-Tonneau D
J Immunol; 1994 May; 152(9):4475-88. PubMed ID: 7512597
[TBL] [Abstract][Full Text] [Related]
10. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
Dis Markers; 1990; 8(2):101-2. PubMed ID: 2387121
[No Abstract] [Full Text] [Related]
11. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
[TBL] [Abstract][Full Text] [Related]
12. HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis.
Mann DL; Lasane F; Popovic M; Arthur LO; Robey WG; Blattner WA; Newman MJ
J Immunol; 1987 Apr; 138(8):2640-4. PubMed ID: 3031162
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.
Farrar WL; Harel-Bellan A; Ferris DK
Crit Rev Immunol; 1988; 8(4):315-39. PubMed ID: 2850890
[TBL] [Abstract][Full Text] [Related]
14. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.
Landau NR; Warton M; Littman DR
Nature; 1988 Jul; 334(6178):159-62. PubMed ID: 3260352
[TBL] [Abstract][Full Text] [Related]
15. Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120.
Merkenschlager M; Buck D; Beverley PC; Sattentau QJ
J Immunol; 1990 Nov; 145(9):2839-45. PubMed ID: 1698863
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
[TBL] [Abstract][Full Text] [Related]
17. A soluble form of CD4 (T4) protein inhibits AIDS virus infection.
Deen KC; McDougal JS; Inacker R; Folena-Wasserman G; Arthos J; Rosenberg J; Maddon PJ; Axel R; Sweet RW
Nature; 1988 Jan; 331(6151):82-4. PubMed ID: 3257544
[TBL] [Abstract][Full Text] [Related]
18. HIV-gp120 can block CD4-class II MHC-mediated adhesion.
Rosenstein Y; Burakoff SJ; Herrmann SH
J Immunol; 1990 Jan; 144(2):526-31. PubMed ID: 1967269
[TBL] [Abstract][Full Text] [Related]
19. Recognition of HIV glycoprotein gp120 by T cells. Role of monocyte CD4 in the presentation of gp120.
Siliciano RF; Knall C; Lawton T; Berman P; Gregory T; Reinherz EL
J Immunol; 1989 Mar; 142(5):1506-11. PubMed ID: 2537355
[TBL] [Abstract][Full Text] [Related]
20. Development of CD4-CD8+ cytotoxic T cells requires interactions with class I MHC determinants.
Maruŝić-Galesić S; Stephany DA; Longo DL; Kruisbeek AM
Nature; 1988 May; 333(6169):180-3. PubMed ID: 3259290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
